Novartis shares experienced a surge on Tuesday following the announcement by the Swiss pharmaceutical company that it has raised its full-year guidance due to strong drug sales. In addition to this, Novartis also unveiled a $15 billion share buyback plan. The company’s positive financial performance was revealed during the release of its second-quarter earnings report, …
Jay Reinstein, an individual suffering from Alzheimer’s, recently underwent a PET scan at MedStar Georgetown University Hospital in Washington, DC on June 20, 2023. Michael Robinson Chávez | The Washington Post | Getty Images Medicare is planning to expand its coverage of PET scans, a diagnostic tool used in the detection of Alzheimer’s disease. This …
Pavlo Gonchar | LightRocket | Getty Images Johnson & Johnson filed a lawsuit against the Biden administration on Tuesday regarding Medicare’s new authority to reduce drug prices. This marks the third pharmaceutical company to challenge this controversial provision of the Inflation Reduction Act. The lawsuit, which was filed in a federal district court in New …
Supporters, along with disability advocates, raised Save Medicaid signs during a Senate Democrats’ news conference at the Capitol. This was done in opposition to the Republicans’ Graham-Cassidy health care bill. Approximately 3 million individuals have been removed from Medicaid since April, following the expiration of Covid-19 pandemic protections. Shockingly, 75% of those affected were still …
Blood sample for respiratory syncytial virus (RSV) test Jarun011 | Istock | Getty Images The Food and Drug Administration (FDA) has granted approval on Monday for AstraZeneca and Sanofi’s breakthrough shot that provides protection against respiratory syncytial virus (RSV) in infants and toddlers. RSV is the primary cause of hospitalization among babies in the U.S. …
Eli Lilly and Company, a pharmaceutical company based in Madrid, Spain, announced on Monday that it has submitted an application for full approval of its Alzheimer’s treatment, donanemab, to the U.S. Food and Drug Administration (FDA). The company anticipates a decision from the FDA by the end of the year. This application is supported by …
A package of the daily contraceptive Opill is seen in an undated illustration. Perrigo | via Reuters The availability of the first over-the-counter birth control pill in the U.S. may still be limited for some women and girls due to insurance coverage issues. The U.S. Food and Drug Administration recently granted approval for the sale …
Eli Lilly and Company, a prominent pharmaceutical company headquartered in Alcobendas, Madrid, Spain, has announced its acquisition of Versanis, a privately held obesity drug maker, for a staggering sum of up to $1.93 billion. This strategic move aims to enhance Eli Lilly’s weight loss treatment portfolio. The transaction will see Eli Lilly make cash payments …
Cans of PepsiCo’s Pepsi Zero Sugar soda are displayed for an arranged photograph taken in Tiskilwa, Illinois, on Wednesday, April 17, 2019. Daniel Acker | Bloomberg | Getty Images The U.S. Food and Drug Administration disagrees with a World Health Organization (WHO) finding that the widely used soda sweetener, aspartame, is possibly carcinogenic to humans. …
Representatives engage with customers at a UnitedHealthcare store in Queens, New York. Michael Nagle | Bloomberg | Getty Images UnitedHealth Group ‘s stock price surged on Friday after the health-care conglomerate announced second-quarter revenue and adjusted earnings that exceeded Wall Street’s expectations, despite the increase in medical costs. The results alleviated investor concerns following the …